SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare informs about Board Meeting

18 Apr 2013 Evaluate

Cadila Healthcare has informed that a meeting of Audit Committee and the Board of Directors of the Company will be held on April 22, 2013 to consider a proposal for exploring the possibilities for merger of certain wholly owned subsidiary companies with the Company and to approve the draft Scheme of Amalgamation under Section 391-394 of the Companies Act, 1956.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1122.85 23.25 (2.11%)
29-Jul-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1989.75
Dr. Reddys Labs. 1143.20
Cipla 1473.45
Lupin 2446.00
Zydus Lifesciences 1122.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: